DOCSLIB.ORG

Mouse Nrd1 Conditional Knockout Project (CRISPR/Cas9)

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

https://www.alphaknockout.com Mouse Nrd1 Conditional Knockout Project (CRISPR/Cas9) Objective: To create a Nrd1 conditional knockout Mouse model (C57BL/6J) by CRISPR/Cas-mediated genome engineering. Strategy summary: The Nrd1 gene (NCBI Reference Sequence: NM_146150 ; Ensembl: ENSMUSG00000053510 ) is located on Mouse chromosome 4. 31 exons are identified, with the ATG start codon in exon 1 and the TAA stop codon in exon 31 (Transcript: ENSMUST00000065977). Exon 4 will be selected as conditional knockout region (cKO region). Deletion of this region should result in the loss of function of the Mouse Nrd1 gene. To engineer the targeting vector, homologous arms and cKO region will be generated by PCR using BAC clone RP23-315E18 as template. Cas9, gRNA and targeting vector will be co-injected into fertilized eggs for cKO Mouse production. The pups will be genotyped by PCR followed by sequencing analysis. Note: Mice homozygous for a knock-out allele mostly die within 48 hours of birth with surviving mice exhibiting cortical thinning, enlarged lateral ventricles, hypomyelination, reduced grip strength, impaired coordination, and impaired spatial working memory. Exon 4 starts from about 21.42% of the coding region. The knockout of Exon 4 will result in frameshift of the gene. The size of intron 3 for 5'-loxP site insertion: 1037 bp, and the size of intron 4 for 3'-loxP site insertion: 5092 bp. The size of effective cKO region: ~654 bp. The cKO region does not have any other known gene. Page 1 of 8 https://www.alphaknockout.com Overview of the Targeting Strategy Wildtype allele gRNA region 5' gRNA region 3' 1 3 4 31 Targeting vector Targeted allele Constitutive KO allele (After Cre recombination) Legends Exon of mouse Nrd1 Homology arm cKO region loxP site Page 2 of 8 https://www.alphaknockout.com Overview of the Dot Plot Window size: 10 bp Forward Reverse Complement Sequence 12 Note: The sequence of homologous arms and cKO region is aligned with itself to determine if there are tandem repeats. No significant tandem repeat is found in the dot plot matrix. So this region is suitable for PCR screening or sequencing analysis. Overview of the GC Content Distribution Window size: 300 bp Sequence 12 Summary: Full Length(7154bp) | A(30.58% 2188) | C(17.19% 1230) | T(32.44% 2321) | G(19.78% 1415) Note: The sequence of homologous arms and cKO region is analyzed to determine the GC content. No significant high GC-content region is found. So this region is suitable for PCR screening or sequencing analysis. Page 3 of 8 https://www.alphaknockout.com BLAT Search Results (up) QUERY SCORE START END QSIZE IDENTITY CHROM STRAND START END SPAN ----------------------------------------------------------------------------------------------- browser details YourSeq 3000 1 3000 3000 100.0% chr4 + 109015709 109018708 3000 browser details YourSeq 74 2421 2620 3000 92.1% chr1 + 119900235 119900456 222 browser details YourSeq 68 2436 2619 3000 81.7% chr16 + 5314936 5315486 551 browser details YourSeq 67 2446 2631 3000 81.0% chr11 + 55177855 55178077 223 browser details YourSeq 60 2522 2629 3000 94.2% chr3 + 28576913 28577090 178 browser details YourSeq 59 2437 2572 3000 81.2% chr1 + 167413339 167413464 126 browser details YourSeq 56 2440 2610 3000 81.9% chr9 + 14684234 14684425 192 browser details YourSeq 55 2442 2535 3000 84.9% chr11 + 116587463 116587557 95 browser details YourSeq 53 2460 2628 3000 92.1% chr14 - 86294089 86294259 171 browser details YourSeq 52 2464 2616 3000 94.9% chr5 - 4022026 4022205 180 browser details YourSeq 52 2440 2616 3000 92.0% chr11 + 21196001 21196206 206 browser details YourSeq 51 2436 2616 3000 91.9% chr10 - 67310193 67310404 212 browser details YourSeq 51 2458 2536 3000 88.0% chr6 + 114056195 114056271 77 browser details YourSeq 49 2444 2539 3000 80.0% chr9 - 113642796 113642890 95 browser details YourSeq 47 2458 2537 3000 75.7% chr11 - 114046328 114046405 78 browser details YourSeq 47 2426 2516 3000 79.8% chr11 - 80195659 80195756 98 browser details YourSeq 47 2458 2518 3000 88.6% chr2 + 174447921 174447981 61 browser details YourSeq 47 2548 2628 3000 92.9% chr12 + 84024469 84024794 326 browser details YourSeq 47 2553 2630 3000 94.5% chr12 + 78186446 78186523 78 browser details YourSeq 46 2439 2516 3000 92.6% chr4 + 134379604 134379683 80 Note: The 3000 bp section upstream of Exon 4 is BLAT searched against the genome. No significant similarity is found. BLAT Search Results (down) QUERY SCORE START END QSIZE IDENTITY CHROM STRAND START END SPAN ----------------------------------------------------------------------------------------------- browser details YourSeq 3000 1 3000 3000 100.0% chr4 + 109019363 109022362 3000 browser details YourSeq 52 1350 1427 3000 95.0% chr1 + 189724892 189725115 224 browser details YourSeq 46 1354 1407 3000 96.3% chr1 + 73454983 73455065 83 browser details YourSeq 45 67 212 3000 88.0% chr1 - 83757490 83757667 178 browser details YourSeq 45 1352 1400 3000 98.0% chr10 + 100937814 100938014 201 browser details YourSeq 45 1350 1401 3000 94.2% chr10 + 24941079 24941134 56 browser details YourSeq 45 1352 1400 3000 96.0% chr10 + 5058663 5058711 49 browser details YourSeq 44 1352 1400 3000 96.0% chr10 + 78844797 78844849 53 browser details YourSeq 44 1352 1400 3000 96.0% chr1 + 14949748 14949798 51 browser details YourSeq 43 1352 1400 3000 96.0% chr1 + 128552413 128552481 69 browser details YourSeq 42 1350 1395 3000 97.9% chr1 - 165035104 165035163 60 browser details YourSeq 42 1350 1395 3000 97.9% chr10 + 80362565 80362819 255 browser details YourSeq 42 1352 1400 3000 87.3% chr10 + 5058645 5058691 47 browser details YourSeq 42 1350 1392 3000 100.0% chr1 + 160473084 160473172 89 browser details YourSeq 41 1350 1394 3000 97.8% chr1 - 110573755 110573811 57 browser details YourSeq 41 1350 1395 3000 95.7% chr1 - 4258690 4258852 163 browser details YourSeq 41 1350 1394 3000 95.6% chr1 - 4258657 4258701 45 browser details YourSeq 40 1350 1394 3000 95.6% chr1 - 76730075 76730165 91 browser details YourSeq 40 1352 1394 3000 97.7% chr1 - 76730141 76730187 47 browser details YourSeq 40 1352 1394 3000 97.7% chr1 - 25105094 25105210 117 Note: The 3000 bp section downstream of Exon 4 is BLAT searched against the genome. No significant similarity is found. Page 4 of 8 https://www.alphaknockout.com Gene and protein information: Nrd1 nardilysin, N-arginine dibasic convertase, NRD convertase 1 [ Mus musculus (house mouse) ] Gene ID: 230598, updated on 10-Oct-2019 Gene summary Official Symbol Nrd1 provided by MGI Official Full Name nardilysin, N-arginine dibasic convertase, NRD convertase 1 provided by MGI Primary source MGI:MGI:1201386 See related Ensembl:ENSMUSG00000053510 Gene type protein coding RefSeq status VALIDATED Organism Mus musculus Lineage Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; Murinae; Mus; Mus Also known as Nrdc; NRD-C; AI875733; 2600011I06Rik Expression Broad expression in testis adult (RPKM 91.8), CNS E11.5 (RPKM 25.7) and 22 other tissues See more Orthologs human all Genomic context Location: 4; 4 C7 See Nrd1 in Genome Data Viewer Exon count: 33 Annotation release Status Assembly Chr Location 108 current GRCm38.p6 (GCF_000001635.26) 4 NC_000070.6 (109000655..109061777) Build 37.2 previous assembly MGSCv37 (GCF_000001635.18) 4 NC_000070.5 (108673410..108734376) Chromosome 4 - NC_000070.6 Page 5 of 8 https://www.alphaknockout.com Transcript information: This gene has 12 transcripts Gene: Nrd1 ENSMUSG00000053510 Description nardilysin, N-arginine dibasic convertase, NRD convertase 1 [Source:MGI Symbol;Acc:MGI:1201386] Gene Synonyms NRD-C Location Chromosome 4: 109,000,655-109,061,777 forward strand. GRCm38:CM000997.2 About this gene This gene has 12 transcripts (splice variants), 287 orthologues, 6 paralogues, is a member of 1 Ensembl protein family and is associated with 15 phenotypes. Transcripts Name Transcript ID bp Protein Translation ID Biotype CCDS UniProt Flags Nrd1-201 ENSMUST00000065977.10 4311 1161aa ENSMUSP00000068328.4 Protein coding CCDS18460 Q8BHG1 TSL:1 GENCODE basic APPRIS P3 Nrd1-203 ENSMUST00000106644.8 3784 1229aa ENSMUSP00000102255.2 Protein coding CCDS84773 A2A9Q2 TSL:5 GENCODE basic APPRIS ALT2 Nrd1-202 ENSMUST00000102736.8 4179 1117aa ENSMUSP00000099797.2 Protein coding - A6PWC3 TSL:1 GENCODE basic APPRIS ALT2 Nrd1-205 ENSMUST00000125645.1 2190 395aa ENSMUSP00000122808.1 Protein coding - Q3V3G9 CDS 3' incomplete TSL:1 Nrd1-207 ENSMUST00000143604.1 966 No protein - Retained intron - - TSL:2 Nrd1-204 ENSMUST00000125063.1 781 No protein - Retained intron - - TSL:5 Nrd1-209 ENSMUST00000150177.7 604 No protein - Retained intron - - TSL:2 Nrd1-212 ENSMUST00000155228.1 560 No protein - Retained intron - - TSL:2 Nrd1-206 ENSMUST00000143015.1 534 No protein - Retained intron - - TSL:2 Nrd1-211 ENSMUST00000150796.1 164 No protein - Retained intron - - TSL:3 Nrd1-210 ENSMUST00000150784.7 1958 No protein - lncRNA - - TSL:1 Nrd1-208 ENSMUST00000148444.1 363 No protein - lncRNA - - TSL:5 Page 6 of 8 https://www.alphaknockout.com 81.12 kb Forward strand 109.00Mb 109.02Mb 109.04Mb 109.06Mb Genes Nrd1-202 >protein coding (Comprehensive set... Nrd1-201 >protein coding Nrd1-203 >protein coding Nrd1-205 >protein coding Nrd1-208 >lncRNA Nrd1-206 >retained intron Mir761-201 >miRNA Nrd1-209 >retained intron Nrd1-211 >retained intron Nrd1-212 >retained intron Nrd1-207 >retained intron Nrd1-204 >retained intron Nrd1-210 >lncRNA Contigs AL627406.15 > Genes < Gm23589-201snRNA < Osbpl9-211nonsense
Recommended publications
  • Analysis of Gene Expression Data for Gene Ontology

    Analysis of Gene Expression Data for Gene Ontology

    ANALYSIS OF GENE EXPRESSION DATA FOR GENE ONTOLOGY BASED PROTEIN FUNCTION PREDICTION A Thesis Presented to The Graduate Faculty of The University of Akron In Partial Fulfillment of the Requirements for the Degree Master of Science Robert Daniel Macholan May 2011 ANALYSIS OF GENE EXPRESSION DATA FOR GENE ONTOLOGY BASED PROTEIN FUNCTION PREDICTION Robert Daniel Macholan Thesis Approved: Accepted: _______________________________ _______________________________ Advisor Department Chair Dr. Zhong-Hui Duan Dr. Chien-Chung Chan _______________________________ _______________________________ Committee Member Dean of the College Dr. Chien-Chung Chan Dr. Chand K. Midha _______________________________ _______________________________ Committee Member Dean of the Graduate School Dr. Yingcai Xiao Dr. George R. Newkome _______________________________ Date ii ABSTRACT A tremendous increase in genomic data has encouraged biologists to turn to bioinformatics in order to assist in its interpretation and processing. One of the present challenges that need to be overcome in order to understand this data more completely is the development of a reliable method to accurately predict the function of a protein from its genomic information. This study focuses on developing an effective algorithm for protein function prediction. The algorithm is based on proteins that have similar expression patterns. The similarity of the expression data is determined using a novel measure, the slope matrix. The slope matrix introduces a normalized method for the comparison of expression levels throughout a proteome. The algorithm is tested using real microarray gene expression data. Their functions are characterized using gene ontology annotations. The results of the case study indicate the protein function prediction algorithm developed is comparable to the prediction algorithms that are based on the annotations of homologous proteins.
  • A Computational and Evolutionary Approach to Understanding Cryptic Unstable Transcripts in Yeast

    A Computational and Evolutionary Approach to Understanding Cryptic Unstable Transcripts in Yeast

    A Computational and Evolutionary Approach to Understanding Cryptic Unstable Transcripts in Yeast By Jessica M. Vera B.S. University of Wisconsin-Madison, 2007 A thesis submitted to the Faculty of the Graduate School in partial fulfillment of the requirements for the degree of Doctor of Philosophy Department of Molecular, Cellular, and Developmental Biology 2015 This thesis entitled: A Computational and Evolutionary Approach to Understanding Cryptic Unstable Transcripts in Yeast written by Jessica M. Vera has been approved for the Department of Molecular, Cellular, and Developmental Biology Tom Blumenthal Robin Dowell Date The final copy of this thesis has been examined by the signatories, and we find that both the content and the form meet acceptable presentation standards of scholarly work in the above mentioned discipline iii Vera, Jessica M. (Ph.D., Molecular, Cellular and Developmental Biology) A Computational and Evolutionary Approach to Understanding Cryptic Unstable Transcripts in Yeast Thesis Directed by Robin Dowell Cryptic unstable transcripts (CUTs) are a largely unexplored class of nuclear exosome degraded, non-coding RNAs in budding yeast. It is highly debated whether CUT transcription has a functional role in the cell or whether CUTs represent noise in the yeast transcriptome. I sought to ascertain the extent of conserved CUT expression across a variety of Saccharomyces yeast strains to further understand and characterize the nature of CUT expression. To this end I designed a Hidden Markov Model (HMM) to analyze strand-specific RNA sequencing data from nuclear exosome rrp6Δ mutants to identify and compare CUTs in four different yeast strains: S288c, Σ1278b, JAY291 (S.cerevisiae) and N17 (S.paradoxus).
  • PAR-CLIP Data Indicate That Nrd1-Nab3

    PAR-CLIP Data Indicate That Nrd1-Nab3

    Webb et al. Genome Biology 2014, 15:R8 http://genomebiology.com/2014/15/1/R8 RESEARCH Open Access PAR-CLIP data indicate that Nrd1-Nab3-dependent transcription termination regulates expression of hundreds of protein coding genes in yeast Shaun Webb2, Ralph D Hector1, Grzegorz Kudla3 and Sander Granneman1,2* Abstract Background: Nrd1 and Nab3 are essential sequence-specific yeast RNA binding proteins that function as a heterodimer in the processing and degradation of diverse classes of RNAs. These proteins also regulate several mRNA coding genes; however, it remains unclear exactly what percentage of the mRNA component of the transcriptome these proteins control. To address this question, we used the pyCRAC software package developed in our laboratory to analyze CRAC and PAR-CLIP data for Nrd1-Nab3-RNA interactions. Results: We generated high-resolution maps of Nrd1-Nab3-RNA interactions, from which we have uncovered hundreds of new Nrd1-Nab3 mRNA targets, representing between 20 and 30% of protein-coding transcripts. Although Nrd1 and Nab3 showed a preference for binding near 5′ ends of relatively short transcripts, they bound transcripts throughout coding sequences and 3′ UTRs. Moreover, our data for Nrd1-Nab3 binding to 3′ UTRs was consistent with a role for these proteins in the termination of transcription. Our data also support a tight integration of Nrd1-Nab3 with the nutrient response pathway. Finally, we provide experimental evidence for some of our predictions, using northern blot and RT-PCR assays. Conclusions: Collectively, our data support the notion that Nrd1 and Nab3 function is tightly integrated with the nutrient response and indicate a role for these proteins in the regulation of many mRNA coding genes.
  • RNA Polymerase II CTD Phosphatase Rtr1 Fine-Tunes Transcription Termination

    RNA Polymerase II CTD Phosphatase Rtr1 Fine-Tunes Transcription Termination

    PLOS GENETICS RESEARCH ARTICLE RNA Polymerase II CTD phosphatase Rtr1 fine-tunes transcription termination 1☯ 1☯ 1 Jose F. VictorinoID , Melanie J. FoxID , Whitney R. Smith-KinnamanID , Sarah A. Peck 1 1 1 1 1 JusticeID , Katlyn H. BurrissID , Asha K. Boyd , Megan A. Zimmerly , Rachel R. Chan , 1 2,3 1,3¤ Gerald O. Hunter , Yunlong LiuID , Amber L. MosleyID * 1 Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, Indiana, United States of America, 2 Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, Indiana, United States of America, 3 Center for Computational Biology and Bioinformatics, Indiana University School of Medicine, Indianapolis, Indiana, United States of America a1111111111 a1111111111 ☯ These authors contributed equally to this work. a1111111111 ¤ Current address: Amber L. Mosley, Department of Biochemistry and Molecular Biology, Indiana University a1111111111 School of Medicine, Indianapolis, Indiana, United States of America a1111111111 * [email protected] Abstract OPEN ACCESS RNA Polymerase II (RNAPII) transcription termination is regulated by the phosphorylation Citation: Victorino JF, Fox MJ, Smith-Kinnaman status of the C-terminal domain (CTD). The phosphatase Rtr1 has been shown to regulate WR, Peck Justice SA, Burriss KH, Boyd AK, et al. serine 5 phosphorylation on the CTD; however, its role in the regulation of RNAPII termina- (2020) RNA Polymerase II CTD phosphatase Rtr1 tion has not been explored. As a consequence of RTR1 deletion, interactions within the ter- fine-tunes transcription termination. PLoS Genet mination machinery and between the termination machinery and RNAPII were altered as 16(3): e1008317. https://doi.org/10.1371/journal.
  • Aneuploidy: Using Genetic Instability to Preserve a Haploid Genome?

    Aneuploidy: Using Genetic Instability to Preserve a Haploid Genome?

    Health Science Campus FINAL APPROVAL OF DISSERTATION Doctor of Philosophy in Biomedical Science (Cancer Biology) Aneuploidy: Using genetic instability to preserve a haploid genome? Submitted by: Ramona Ramdath In partial fulfillment of the requirements for the degree of Doctor of Philosophy in Biomedical Science Examination Committee Signature/Date Major Advisor: David Allison, M.D., Ph.D. Academic James Trempe, Ph.D. Advisory Committee: David Giovanucci, Ph.D. Randall Ruch, Ph.D. Ronald Mellgren, Ph.D. Senior Associate Dean College of Graduate Studies Michael S. Bisesi, Ph.D. Date of Defense: April 10, 2009 Aneuploidy: Using genetic instability to preserve a haploid genome? Ramona Ramdath University of Toledo, Health Science Campus 2009 Dedication I dedicate this dissertation to my grandfather who died of lung cancer two years ago, but who always instilled in us the value and importance of education. And to my mom and sister, both of whom have been pillars of support and stimulating conversations. To my sister, Rehanna, especially- I hope this inspires you to achieve all that you want to in life, academically and otherwise. ii Acknowledgements As we go through these academic journeys, there are so many along the way that make an impact not only on our work, but on our lives as well, and I would like to say a heartfelt thank you to all of those people: My Committee members- Dr. James Trempe, Dr. David Giovanucchi, Dr. Ronald Mellgren and Dr. Randall Ruch for their guidance, suggestions, support and confidence in me. My major advisor- Dr. David Allison, for his constructive criticism and positive reinforcement.
  • A Yeast Phenomic Model for the Influence of Warburg Metabolism on Genetic Buffering of Doxorubicin Sean M

    A Yeast Phenomic Model for the Influence of Warburg Metabolism on Genetic Buffering of Doxorubicin Sean M

    Santos and Hartman Cancer & Metabolism (2019) 7:9 https://doi.org/10.1186/s40170-019-0201-3 RESEARCH Open Access A yeast phenomic model for the influence of Warburg metabolism on genetic buffering of doxorubicin Sean M. Santos and John L. Hartman IV* Abstract Background: The influence of the Warburg phenomenon on chemotherapy response is unknown. Saccharomyces cerevisiae mimics the Warburg effect, repressing respiration in the presence of adequate glucose. Yeast phenomic experiments were conducted to assess potential influences of Warburg metabolism on gene-drug interaction underlying the cellular response to doxorubicin. Homologous genes from yeast phenomic and cancer pharmacogenomics data were analyzed to infer evolutionary conservation of gene-drug interaction and predict therapeutic relevance. Methods: Cell proliferation phenotypes (CPPs) of the yeast gene knockout/knockdown library were measured by quantitative high-throughput cell array phenotyping (Q-HTCP), treating with escalating doxorubicin concentrations under conditions of respiratory or glycolytic metabolism. Doxorubicin-gene interaction was quantified by departure of CPPs observed for the doxorubicin-treated mutant strain from that expected based on an interaction model. Recursive expectation-maximization clustering (REMc) and Gene Ontology (GO)-based analyses of interactions identified functional biological modules that differentially buffer or promote doxorubicin cytotoxicity with respect to Warburg metabolism. Yeast phenomic and cancer pharmacogenomics data were integrated to predict differential gene expression causally influencing doxorubicin anti-tumor efficacy. Results: Yeast compromised for genes functioning in chromatin organization, and several other cellular processes are more resistant to doxorubicin under glycolytic conditions. Thus, the Warburg transition appears to alleviate requirements for cellular functions that buffer doxorubicin cytotoxicity in a respiratory context.
  • OSBPL9 (NM 148907) Human Tagged ORF Clone Lentiviral Particle Product Data

    OSBPL9 (NM 148907) Human Tagged ORF Clone Lentiviral Particle Product Data

    OriGene Technologies, Inc. 9620 Medical Center Drive, Ste 200 Rockville, MD 20850, US Phone: +1-888-267-4436 [email protected] EU: [email protected] CN: [email protected] Product datasheet for RC221526L4V OSBPL9 (NM_148907) Human Tagged ORF Clone Lentiviral Particle Product data: Product Type: Lentiviral Particles Product Name: OSBPL9 (NM_148907) Human Tagged ORF Clone Lentiviral Particle Symbol: OSBPL9 Synonyms: ORP-9; ORP9 Vector: pLenti-C-mGFP-P2A-Puro (PS100093) ACCN: NM_148907 ORF Size: 1878 bp ORF Nucleotide The ORF insert of this clone is exactly the same as(RC221526). Sequence: OTI Disclaimer: The molecular sequence of this clone aligns with the gene accession number as a point of reference only. However, individual transcript sequences of the same gene can differ through naturally occurring variations (e.g. polymorphisms), each with its own valid existence. This clone is substantially in agreement with the reference, but a complete review of all prevailing variants is recommended prior to use. More info OTI Annotation: This clone was engineered to express the complete ORF with an expression tag. Expression varies depending on the nature of the gene. RefSeq: NM_148907.1 RefSeq Size: 2694 bp RefSeq ORF: 1881 bp Locus ID: 114883 UniProt ID: Q96SU4 MW: 70.1 kDa This product is to be used for laboratory only. Not for diagnostic or therapeutic use. View online » ©2021 OriGene Technologies, Inc., 9620 Medical Center Drive, Ste 200, Rockville, MD 20850, US 1 / 2 OSBPL9 (NM_148907) Human Tagged ORF Clone Lentiviral Particle – RC221526L4V Gene Summary: This gene encodes a member of the oxysterol-binding protein (OSBP) family, a group of intracellular lipid receptors.
  • OSBPL9 (NM 148906) Human Tagged ORF Clone – RC221011L3

    OSBPL9 (NM 148906) Human Tagged ORF Clone – RC221011L3

    OriGene Technologies, Inc. 9620 Medical Center Drive, Ste 200 Rockville, MD 20850, US Phone: +1-888-267-4436 [email protected] EU: [email protected] CN: [email protected] Product datasheet for RC221011L3 OSBPL9 (NM_148906) Human Tagged ORF Clone Product data: Product Type: Expression Plasmids Product Name: OSBPL9 (NM_148906) Human Tagged ORF Clone Tag: Myc-DDK Symbol: OSBPL9 Synonyms: ORP-9; ORP9 Vector: pLenti-C-Myc-DDK-P2A-Puro (PS100092) E. coli Selection: Chloramphenicol (34 ug/mL) Cell Selection: Puromycin ORF Nucleotide The ORF insert of this clone is exactly the same as(RC221011). Sequence: Restriction Sites: SgfI-MluI Cloning Scheme: ACCN: NM_148906 ORF Size: 1713 bp This product is to be used for laboratory only. Not for diagnostic or therapeutic use. View online » ©2021 OriGene Technologies, Inc., 9620 Medical Center Drive, Ste 200, Rockville, MD 20850, US 1 / 2 OSBPL9 (NM_148906) Human Tagged ORF Clone – RC221011L3 OTI Disclaimer: The molecular sequence of this clone aligns with the gene accession number as a point of reference only. However, individual transcript sequences of the same gene can differ through naturally occurring variations (e.g. polymorphisms), each with its own valid existence. This clone is substantially in agreement with the reference, but a complete review of all prevailing variants is recommended prior to use. More info OTI Annotation: This clone was engineered to express the complete ORF with an expression tag. Expression varies depending on the nature of the gene. RefSeq: NM_148906.1, NP_683704.1 RefSeq Size: 2840 bp RefSeq ORF: 2160 bp Locus ID: 114883 UniProt ID: Q96SU4 MW: 63.7 kDa Gene Summary: This gene encodes a member of the oxysterol-binding protein (OSBP) family, a group of intracellular lipid receptors.
  • Measuring Gene Expression Part 3 Key Steps in Microarray Analysis

    Measuring Gene Expression Part 3 Key Steps in Microarray Analysis

    Measuring Gene Expression Part 3 David Wishart Bioinformatics 301 [email protected] Key Steps in Microarray Analysis • Quality Control (checking microarrays for errors or problems) • Image Processing – Gridding – Segmentation (peak picking) – Data Extraction (intensity, QC) • Data Analysis and Data Mining Comet Tailing • Often caused by insufficiently rapid immersion of the slides in the succinic anhydride blocking solution. Uneven Spotting/Blotting • Problems with print tips or with overly viscous solution • Problems with humidity in spottiing chamber High Background • Insufficient Blocking • Precipitation of labelled probe Gridding Errors Spotting errors Uneven hybridization Gridding errors Key Steps in Microarray Analysis • Quality Control (checking microarrays for errors or problems) • Image Processing – Gridding – Segmentation (spot picking) – Data Extraction (intensity, QC) • Data Analysis and Data Mining Microarray Scanning PMT Pinhole Detector lens Laser Beam-splitter Objective Lens Dye Glass Slide Microarray Principles Laser 1 Laser 2 Green channel Red channel Scan and detect with overlay images Image process confocal laser system and normalize and analyze Microarray Images • Resolution – standard 10µm [currently, max 5µm] – 100µm spot on chip = 10 pixels in diameter • Image format – TIFF (tagged image file format) 16 bit (64K grey levels) – 1cm x 1cm image at 16 bit = 2Mb (uncompressed) – other formats exist i.e. SCN (Stanford University) • Separate image for each fluorescent sample – channel 1, channel 2, etc. Image
  • Adverse Childhood Experiences, Epigenetic Measures, and Obesity in Youth

    Adverse Childhood Experiences, Epigenetic Measures, and Obesity in Youth

    ORIGINAL www.jpeds.com • THE JOURNAL OF PEDIATRICS ARTICLES Adverse Childhood Experiences, Epigenetic Measures, and Obesity in Youth Joan Kaufman, PhD1,2,3, Janitza L. Montalvo-Ortiz, PhD3, Hannah Holbrook,BA4, Kerry O'Loughlin,BA4, Catherine Orr, PhD4, Catherine Kearney,MA1, Bao-Zhu Yang, PhD3, Tao Wang, PhD5,6, Hongyu Zhao, PhD5, Robert Althoff, MD, PhD4, Hugh Garavan, PhD4, Joel Gelernter,MD3,7, and James Hudziak,MD4 Objective To determine if measures of adverse childhood experiences and DNA methylation relate to indices of obesity in youth. Study design Participants were derived from a cohort of 321 8 to 15-year-old children recruited for an investi- gation examining risk and resilience and psychiatric outcomes in maltreated children. Assessments of obesity were collected as an add-on for a subset of 234 participants (56% female; 52% maltreated). Illumina arrays were used to examine whole genome epigenetic predictors of obesity in saliva DNA. For analytic purposes, the cohort ana- lyzed in the first batch comprised the discovery sample (n = 160), and the cohort analyzed in the second batch the replication sample (n = 74). Results After controlling for race, sex, age, cell heterogeneity, 3 principal components, and whole genome testing, 10 methylation sites were found to interact with adverse childhood experiences to predict cross-sectional mea- sures of body mass index, and an additional 6 sites were found to exert a main effect in predicting body mass index (P < 5.0 × 10−7, all comparisons). Eight of the methylation sites were in genes previously associated with obesity risk (eg, PCK2, CxCl10, BCAT1, HID1, PRDM16, MADD, PXDN, GALE), with several of the findings from the dis- covery data set replicated in the second cohort.
  • Supporting Information

    Supporting Information

    Supporting Information Friedman et al. 10.1073/pnas.0812446106 SI Results and Discussion intronic miR genes in these protein-coding genes. Because in General Phenotype of Dicer-PCKO Mice. Dicer-PCKO mice had many many cases the exact borders of the protein-coding genes are defects in additional to inner ear defects. Many of them died unknown, we searched for miR genes up to 10 kb from the around birth, and although they were born at a similar size to hosting-gene ends. Out of the 488 mouse miR genes included in their littermate heterozygote siblings, after a few weeks the miRBase release 12.0, 192 mouse miR genes were found as surviving mutants were smaller than their heterozygote siblings located inside (distance 0) or in the vicinity of the protein-coding (see Fig. 1A) and exhibited typical defects, which enabled their genes that are expressed in the P2 cochlear and vestibular SE identification even before genotyping, including typical alopecia (Table S2). Some coding genes include huge clusters of miRNAs (in particular on the nape of the neck), partially closed eyelids (e.g., Sfmbt2). Other genes listed in Table S2 as coding genes are [supporting information (SI) Fig. S1 A and C], eye defects, and actually predicted, as their transcript was detected in cells, but weakness of the rear legs that were twisted backwards (data not the predicted encoded protein has not been identified yet, and shown). However, while all of the mutant mice tested exhibited some of them may be noncoding RNAs. Only a single protein- similar deafness and stereocilia malformation in inner ear HCs, coding gene that is differentially expressed in the cochlear and other defects were variable in their severity.
  • Genetic Evidence Implicates the Immune System and Cholesterol Metabolism in the Aetiology of Alzheimer's Disease Alison M

    Genetic Evidence Implicates the Immune System and Cholesterol Metabolism in the Aetiology of Alzheimer's Disease Alison M

    Washington University School of Medicine Digital Commons@Becker Open Access Publications 2010 Genetic evidence implicates the immune system and cholesterol metabolism in the aetiology of Alzheimer's disease Alison M. Goate Washington University School of Medicine in St. Louis Carlos Cruchaga Washington University School of Medicine in St. Louis Petra Nowotny Washington University School of Medicine in St. Louis John C. Morris Washington University School of Medicine in St. Louis Kevin Mayo Washington University School of Medicine in St. Louis See next page for additional authors Follow this and additional works at: https://digitalcommons.wustl.edu/open_access_pubs Part of the Medicine and Health Sciences Commons Recommended Citation Goate, Alison M.; Cruchaga, Carlos; Nowotny, Petra; Morris, John C.; Mayo, Kevin; and et al., ,"Genetic evidence implicates the immune system and cholesterol metabolism in the aetiology of Alzheimer's disease." PLoS One.,. e13950. (2010). https://digitalcommons.wustl.edu/open_access_pubs/1093 This Open Access Publication is brought to you for free and open access by Digital Commons@Becker. It has been accepted for inclusion in Open Access Publications by an authorized administrator of Digital Commons@Becker. For more information, please contact [email protected]. Authors Alison M. Goate, Carlos Cruchaga, Petra Nowotny, John C. Morris, Kevin Mayo, and et al. This open access publication is available at Digital Commons@Becker: https://digitalcommons.wustl.edu/open_access_pubs/1093 Genetic Evidence Implicates the Immune System and Cholesterol Metabolism in the Aetiology of Alzheimer’s Disease Lesley Jones1., Peter A. Holmans1., Marian L. Hamshere1, Denise Harold1, Valentina Moskvina1, Dobril Ivanov1, Andrew Pocklington1, Richard Abraham1, Paul Hollingworth1, Rebecca Sims1, Amy Gerrish1, Jaspreet Singh Pahwa1, Nicola Jones1, Alexandra Stretton1, Angharad R.